Opioid REMS Course
Opioid Prescribing: Safe Practice, Changing Lives
The American Pain Society will present a 2-hour session on opioid REMS on Friday, August 4, 2017 in Orlando, Florida and Saturday, November 18, in San Francisco.
David Bazzo, MD
Topics to be discussed during the session include the following:
- the initial assessment of the pain patient
- developing a treatment plan
- assessing risk for abuse
- ongoing reassessment of the patient.
What You Can Expect to Gain
By participating in this meeting, attendees can expect to achieve the following objectives:
- Describe appropriate pain assessment for treatment with extended-release and long-acting (ER/LA) opioid analgesics.
- Evaluate risks, potential benefits, and possible misuse of these medications.
- Apply prescribing best practices for ER/LA opioid analgesics, including initiation of therapy, dosing, conversion, and discontinuation.
- Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics, including application of evidence-based tools and assessment of adverse effects.
- Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
- Review general and product-specific drug information concerning ER/LA opioid analgesics, including identification of adverse effects.
The Risk Evaluation and Mitigation Strategies (Opioid REMS) for Extended-Release, Long-Acting Opioids will offer continuing education (CME/CNE) credit for physicians and nurses. Credit will be awarded for those sessions attended and evaluated. Successful completion requires that participants register for the meeting, attend and participate, and complete an online evaluation and a posttest. Participants will receive their certificates immediately after they submit their evaluations online.
This Live activity, Risk Evaluation and Mitigation Strategies (REMS): Opioid Prescribing: Safe Practice, Changing Lives , with a beginning date of Friday, August 4, 2017 in Orlando and Saturday, November 18, 2017 in San Francisco, has been reviewed and is acceptable for up to 2.0 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Pain Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Pain Society designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 2.0 hours of Category 1 credit for completing this program.
This activity has been submitted to the American Association of Neuroscience Nurses for approval to award contact hours. The American Association of Neuroscience Nurses is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses may receive a maximum of 2.0 contact hours for completing this program.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesics Opioid REMS Program Companies (RPC). Please visit www.er-laopioidREMS.com for a listing of member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesics Opioid REMS education requirements issued by the FDA.